Loading…
Medical Affairs Strategic Summit Virtual has ended
Simple
Expanded
Grid
By Venue
Considerations for Medical Affairs Leadership [clear filter]
Thursday, May 6
 

10:00am EDT

Chairperson’s Opening Remarks
Speakers
avatar for Carol Hoang Roller, PharmD, MBA

Carol Hoang Roller, PharmD, MBA

VP Medical Affairs, Adverum Biotechnologies
Carol Hoang Roller is a pharmaceutical and healthcare executive with experience across multiple sectors of the healthcare industry including biotech, pharmaceutical, managed care, specialty distribution, digital health and gene therapy.  Experience includes domestic and international... Read More →

Thursday May 6, 2021 10:00am - 10:10am EDT
  Considerations for Medical Affairs Leadership

10:10am EDT

Keynote: COVID-19 Pandemic: Challenges of Leadership
  • Review how medical affairs leaders are leading through a changing environment and supporting their teams. Discuss changes in the day-to-day and the vision for the future. 
  • What your organization is doing specifically in launching new therapies virtually, and what persists.
  • Discuss the most important leadership skills needed for COVID and post- COVID environments.
Speakers
avatar for Kirk Shepard

Kirk Shepard

Chief Medical Officer & SVP, Head of Global Medical Affairs OBG, Eisai, Inc.
Dr. Kirk Shepard is a board-certified medical oncologist and hematologist physician. He is currently CMO and Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Inc. Pharmaceutical Company.  Dr. Shepard’s experience in multiple therapeutic areas includes diverse... Read More →

Thursday May 6, 2021 10:10am - 10:40am EDT
  Considerations for Medical Affairs Leadership

10:45am EDT

How to Ensure your Team is Emerging Successfully from the Pandemic
  • Discuss the emergence out of the pandemic, providing lessons learned, and what successful teams are doing differently from others
  • Focus on the different skill sets needed to ensure optimal function in this new environment and tackling these complexities
  • Dive into the activities most impacted by COVID
  • Discuss tactics used to keep team engaged, healthy (physically and mentally), and safe

Moderators
avatar for Barbara Troupin, MD, MBA

Barbara Troupin, MD, MBA

Recent Senior Vice President, Medical Affairs, MyoKardia (acquired by BMS)
Dr. Troupin has 20+ years of pharmaceutical industry C-suite leadership experience as a CMO leading Medical Affairs, Clinical Development, and Regulatory Affairs in small, private and publicly traded pharmaceutical companies. Her most recent role was Senior Vice President Medical... Read More →

Speakers
avatar for Lee Ding, PharmD

Lee Ding, PharmD

Senior Director, Managed Care Liaison of RWE/HEOR, MyoKardia
Lee Ding, PharmD, is a Senior Director, Field Health Economic Outcome Research, at MyoKardia/BMS. Lee has over 25 years of biopharmaceutical and managed care experiences in a variety of settings, such as Genentech/Roche, BlueCross BlueShield health plan and health system. In... Read More →
avatar for Alan Polnariev, PharmD, MS

Alan Polnariev, PharmD, MS

Senior Medical Science Liaison, U.S. Medical Affairs, Renal Therapeutic Area, AstraZeneca
Dr. Alan Polnariev is dedicated to providing value in healthcare by ensuring that the right patient receives the right medication for the right reasons.   As a board-certified pharmacist with clinical, academic and industry experience, Dr. Polnariev commits... Read More →
avatar for Cathy Andorfer, Ph.D.

Cathy Andorfer, Ph.D.

US Field Medical Dermatology Lead, Bristol Myers Squibb
avatar for Tom Pulles, MD

Tom Pulles, MD

Vice President, Head of Medical Affairs & Patient Advocacy, EMEA, Ultragenyx
Tom has almost 20 years of experience in the Pharmaceutical and Biotech Industry. After working in the Royal Netherlands Navy, he held different medical functions in industry, including a privately owned company developing high quality medical education.Since 2011 he lives in Switzerland... Read More →

Thursday May 6, 2021 10:45am - 11:30am EDT
  Considerations for Medical Affairs Leadership

11:35am EDT

Engaging Key Stakeholders via Compliant Virtual Technology
  • Top Medical Affairs trends that will shape how virtual engagement is used post-pandemic
  • The various methods of virtual interaction: real-time, anytime, and hybrid model
  • Real-world case studies of successful virtual work in action
  • What the pace of innovation in virtual interaction means for Medical Affairs teams in the future
Speakers
avatar for Amy Pinelli

Amy Pinelli

Regional Vice President, Business Partnerships, Within3
With more than 23 years of experience in the life sciences industry, Amy partners with medical, clinical and commercial teams to enhance their communication with outside stakeholders. Her leadership in strategic planning, revenue generation, and business consultation has established... Read More →
avatar for Petra Loesch

Petra Loesch

Director Medical Affairs, BeiGene
Petra Loesch, M.S., is a Director of Global Medical Affairs with BeiGene where she focuses on Key Opinion Leader Engagement, Compliance and Patient Advocacy. She closely partners with the Field Medical Team in engagement with external collaborators and thought leaders. . Petra... Read More →

Thursday May 6, 2021 11:35am - 12:05pm EDT
  Considerations for Medical Affairs Leadership

12:05pm EDT

“Meet the Speakers” Zoom Party hosted by Within3
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with the MASS Speaking Faculty and attendees in this zoom breakout room!
Thursday May 6, 2021 12:05pm - 12:35pm EDT
Zoom Room
  Considerations for Medical Affairs Leadership

12:35pm EDT

Observations and Insights: Where do I go from here?
  • What is an insight?
  • Gathering and reporting insights
  • Taking action and following up
  • Company resources and limitations
Speakers
avatar for Brant Jarrett

Brant Jarrett

Executive Director, Head of Medical Affairs, Mallinckrodt Pharmaceuticals
Brant Jarrett is the Executive Director of Field Medical Affairs at Mallinckrodt Pharmaceuticals. He entered Pharma as an MSL and has had various leadership positions in Medical Affairs including Regional Director, National Director, Medical Director, and Sr. Director Field... Read More →

Thursday May 6, 2021 12:35pm - 1:05pm EDT
  Considerations for Medical Affairs Leadership

1:10pm EDT

Making the Case – How Does Medical Affairs Matter?
  • Review the data needed to measure impact, quantifying value of in-person visits, and measuring productivity; making the case to enter back into the field
  • Discuss what type of support worked best for in-house and field teams
  • How to recognize when people are not doing well in this new environment
Moderators
avatar for Susan Malecha, PharmD, MBA

Susan Malecha, PharmD, MBA

Sr. Director, Medical Affairs, Puma Biotechnology
As an accomplished author, Susan Malecha has lectured extensively and is called upon to present the latest developments in the areas of medical affairs for the pharmaceutical industry. Dr. Malecha is an active member of Healthcare Businesswomen’s Association (HBA), as the current... Read More →

Speakers
avatar for Susan Abedi

Susan Abedi

Executive Vice President, Strategy and Insights, 81QD
Susan has more than 20 years of experience developing medical and commercial strategies, building multi-stakeholder value propositions, and improving HCP engagement. As Executive Vice President of Strategy & Insights at 81qd, Susan focuses on developing robust, analytics-driven solutions... Read More →
avatar for Scott McConnell, Pharm.D.

Scott McConnell, Pharm.D.

Vice President Medical Affairs, Chiasma
Scott McConnell, Pharm.D. is currently the VP of Medical Affairs at Chiasma. He has spent the last 15 years in various roles within Medical Affairs at Cubist, Merck, Chiasma and Alkermes. Prior to industry he spent several years in both academic and clinical pharmacy positions... Read More →
avatar for Stacey Curtiss, Pharm.D.

Stacey Curtiss, Pharm.D.

Vice President, Medical Affairs, REGENXBIO Inc.
Stacey is Vice President of Medical Affairs at REGENXBIO. She has over 15 years’ experience in Medical Affairs across large and emerging biotech, gene therapy and digital therapeutics companies supporting Neuroscience, Ophthalmology and Rare Disease therapeutic areas. Prior to... Read More →
avatar for April Adams

April Adams

Sr. Director, Field Medical – Cardiovascular, Bristol Myers Squibb
April Adams is a focused and strategically driven leader in Medical Affairs with over 20 years of experience in the pharmaceutical industry. Her background includes being an MSL, an MSL Regional Director, and Global Director for Field Medical Excellence.  During her career she... Read More →

Thursday May 6, 2021 1:10pm - 1:55pm EDT
  Considerations for Medical Affairs Leadership

2:00pm EDT

The Role of Field Medical in Supporting Diversity Initiatives in Clinical Development
  • Share how a field medical team evolved to emphasize the importance of diversity in clinical trials with clinical trial sites and primary investigators
  • Understand how to leverage external ecosystems and internal partnerships to incorporate diversity and inclusion in medical affairs
  • Review innovative approaches to enhance the engagement and knowledge of the field medical team on diversity in clinical research
Speakers
avatar for Christina Wright

Christina Wright

Senior Regional Medical Science Liaison, Bristol Myers-Squibb
Christina Wright is a Senior Medical Science Liaison at Bristol Myers Squibb (BMS). She obtained her Doctor of Pharmacy from the Florida A&M University College of Pharmacy in 2011. Following graduation, she completed a pharmacy industry fellowship at BMS in Medical Information. Over... Read More →

Thursday May 6, 2021 2:00pm - 2:30pm EDT
  Considerations for Medical Affairs Leadership
 
Filter sessions
Apply filters to sessions.
Wednesday, May 5
Thursday, May 6
Friday, May 7
Zoom Room
  • Considerations for Medical Affairs Leadership
  • Digital Transformation of Medical Affairs
  • Roundtable Discussion
  • Workshop 1
  • Workshop 2
  • Popular